key: cord-0960831-oehvxi03
authors: Eid, Mustafa Mahmood; Zubaidi, Alaa Al
title: Reprint of: Cerebral venous thrombosis in a young patient with COVID-19
date: 2022-04-14
journal: Dis Mon
DOI: 10.1016/j.disamonth.2022.101395
sha: 682f3c7cc9a8e6254fefec842c81134b621ee6cd
doc_id: 960831
cord_uid: oehvxi03

nan

Reprint of: Cerebral venous thrombosis in a young patient with COVID-19

Emergency Department, Al Ain Hospital, Al Ain, U.A.E.

College of Medicine, University of Diyala, Baqubah, Iraq. that COVID-19 may induce a prothrombotic state, as supported by the elevated levels of factor VIII, fibrinogen, D-dimer, and circulating prothrombotic microparticles such as antiphospholipid antibodies. It has been found that the concomitant CVT infection and COVID-19 seem to portend a much poorer prognosis than each condition individually. (4)

A 38-year-old female presented to the emergency department with a headache, left side numbness, and slurred speech. She was referred from another hospital after her swab for SARS-CoV-2 appeared positive. Her referral paper claimed that the patient was admitted due to a stroke experienced before two days. The patient claimed that she complained of headache, left side weakness, and slurred speech on further questioning. Thus, she was admitted as a case of acute stroke and a COVID-19 swab was done routinely for screening on admission. Details on the patient management in that facility were unknown. The patient denied any past medical history.

She gave a history of close contact with an active COVID-19 patient and she was on oral contraceptive pills. The patient's vital signs showed a blood pressure of 125/80 mmHg, a heart rate of 78 beats per minute, a respiratory rate of 18 breaths per minute, a temperature of 36.8 C,

and an oxygen saturation of 99 % on room air. Her chest, cardiovascular and abdominal examination was unremarkable. The patient was alert and oriented to person, place, time, and situation on neurological examination. The cranial nerves and the motor examination were intact and normal coordination was observed. The patient had left upper limb numbness and some slurred speech. The patient's blood tests were unremarkable. Her chest CT showed a right lower lobe subpleural consolidation related to COVID-19 ( Figure 1 ). The patient's brain CT showed right thalamus and right temporal lobe hypodensity (possible infarction) ( Figure 2) . Therefore, the medical on-call was consulted; he reviewed the patient and admitted him. COVID-19

protocol was started and the neurologist was consulted. The neurologist arranged for a brain MRI. The MRI showed features of cerebral venous sinus thrombosis and right thalamic lesion with features suggestive of right thalamus venous infarction (Figure 3 & 4) . Additionally, CT angiography of the head and the neck was requested and showed evidence of filling defect/thrombosis in the straight sinus, right transverse, and sigmoid sinus ( Figure 5 & 6) .

Consequently, the patient was admitted to the intensive care unit. She was treated with heparin infusion for six days and warfarin was added. Within few days, the patient's speech returned to normal and her left upper limb numbness disappeared. Her headache resolved and she became symptoms-free. The patient was discharged on warfarin after nine days, where she was asymptomatic with no neurological deficiencies.  Epsilon-aminocaproic acid.  Thalidomide.  Tamoxifen.  Erythropoietin.  Phytoestrogens.  L-asparaginase.  Heparin -Heparin therapy has been reported to produce thrombotic thrombocytopenia with associated venous sinus thrombosis.

(3)

True/ False Question:

Intracranial hypotension is considered one of the etiology of cerebral venous thrombosis (CVT)?

1-True.

The correct answer is (1-True) Explanation: Isolated cortical venous thrombosis has been associated with intracranial hypotension syndrome, but only rarely. In a study, Schievink and Maya found that CVT was present in only 3 (2.1%) out of 141 patients with spontaneous intracranial hypotension. (3)

I have no conflicts of interest to disclose.

COVID-19 patient with symptomatic bradycardia

Conjunctivitis as initial presenting symptom in a COVID-19 patient

Cerebral Venous Thrombosis: Background, Etiology

Cerebral Venous Thrombosis in Patients with COVID-19 Infection: a Case Series and Systematic Review

of CVT? 1-Levothyroxine. 2-Corticosteroids. 3-Gentamycin. 4-Nifedipine. 5-Pentoxyphyline

The correct answer is (2-Corticosteroids) Explanation: Several medications are reported to increase the risk of CVT, including the following:  Oral contraceptives -Including the third-generation formulations